Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Impact of a Short Course in Pharmacotherapy for Undergraduate Medical Students: An International Multicentre Study - EDM Research Series No. 017
(1995; 23 pages) View the PDF document
Table of Contents
View the documentSummary
View the documentIntroduction
Open this folder and view contentsMaterials and methods
Open this folder and view contentsResults
View the documentDiscussion and conclusion
View the documentAnnex 1: Retention effect
View the documentAnnex 2: Transfer effect
View the documentAnnex 3: Knowledge on treatment of pain
View the documentReferences
View the documentOther documents in the DAP Research Series
View the documentDAP Research Series No. 17
 

Impact of a Short Course in Pharmacotherapy for Undergraduate Medical Students: An International Multicentre Study - EDM Research Series No. 017

World Health Organization
Organisation mondiale de la Santé

WHO/DAP/95.1
English only
Distribution: Limited

Action Programme on Essential Drugs

T.P.G.M. de Vries1

J.S. Bapna3

A.F.B. Mabadeje6

R.H. Henning1

L. Bero4

B. Santoso7

H.V. Hogerzeil2

K.K. Kafle5

A.J. Smith8

1 Department of Clinical Pharmacology, Faculty of Medicine, University of Groningen, Groningen, Netherlands (WHO Collaborating Centre for Pharmacotherapy Teaching and Training)

2 World Health Organization, Action Programme on Essential Drugs, Geneva, Switzerland

3 Department of Pharmacology, Maulana Azad Medical College, New Delhi, India

4 Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, USA

5 Department of Clinical Pharmacology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal

6 Department of Pharmacology, College of Medicine, University of Lagos, Lagos, Nigeria

7 Department of Clinical Pharmacology, Gadjah Mada University, Yogyakarta, Indonesia

8 Discipline of Clinical Pharmacology, Faculty of Medicine, University of Newcastle, Newcastle, Australia

Much research work, particularly in developing countries, at present goes unreported. The reasons for this include the intense competition to publish in the scientific press, and difficulties in matching the research resources of developed countries. The DAP research series was established to provide a forum for the rapid distribution of data and findings relevant to critical areas of drug policy and use. The Action Programme has a firm commitment to national operational research as part of its direct country support. It is also strongly committed to making the findings of such studies widely known and accessible. While every effort is made by the Programme to support studies of the highest possible quality, research skills and resources will vary from country to country. Documents in the DAP research series reflect this variation, and range from reports of very small scale studies, undertaken with minimal resources, to major global research involving substantive financial, scientific and editorial input.

© World Health Organization 1995

This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).

The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stared in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014